Drug Therapy
Drugs are approved in the U.S. by the Food and Drug Administration (FDA) for specific purposes to help guide medical practice.
Related Resources
Antiestrogen Therapy for HHT: A Double-Blind Placebo-Controlled Clinical Trial
Scientific Literature – 2009Laryngoscope. Authors: Eitan Yaniv, Michal Preis, Tuvia Hadar, Jacob Shvero, and Miriam Haddad. This article can be purchased directly from the publisher. Click to view the article description and purchase options.
MorePharmacokinetic-Pharmacodynamic Correlation from Mouse to Human with Pazopanib, a Multikinase Angiogenesis Inhibitor with Potent Antitumor and Antiangiogenic Activity
Scientific Literature – 2007Molecular Cancer Therapeutics. Authors: Rakesh Kumar, Victoria B. Knick, Sharon K. Rudolph, Jennifer H. Johnson, Renae M. Crosby, Ming-Chih Crouthamel, Teresa M. Hopper, Charles G. Miller, Laura E. Harrington, James A. Onori, Robert J. Mullin, Tona M…
MoreRelated News
Knowledge is Power: The 5 Biggest Changes in HHT Care
Knowledge is Power: The 5 Biggest Changes in HHT Care Thurs., February 26th | 7:00 p.m. (ET) Our understanding of HHT is constantly evolving. If you haven’t been to a conference in a few year…
67th ASH Annual Meeting and Exposition
October 2, 2025
2025 HHT Capitol Hill Day
August 6, 2025
2025 HHT Patient and Physician National Conference
July 23, 2025
More Than A Nosebleed: Buddy’s Story
December 13, 2024
